|
SE369470B
(sv)
*
|
1972-06-16 |
1974-09-02 |
Wenner Gren Med Labor Ab |
|
|
US3953609A
(en)
*
|
1974-02-06 |
1976-04-27 |
Microlife Technics, Inc. |
Method for the growth restriction of undesirable digestive system bacteria in animals and the establishment of lactobacillus lactis NRRL B-5628
|
|
WO1982003088A1
(en)
*
|
1981-03-09 |
1982-09-16 |
Corp Cetus |
Vaccines
|
|
SE463598B
(sv)
*
|
1984-11-08 |
1990-12-17 |
Chemical Dynamics Sweden Ab |
Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
|
|
US4839281A
(en)
*
|
1985-04-17 |
1989-06-13 |
New England Medical Center Hospitals, Inc. |
Lactobacillus strains and methods of selection
|
|
US5804179A
(en)
*
|
1985-12-31 |
1998-09-08 |
Research Corporation Technologies, Inc. |
Lactobacillus compositions and methods for treating urinary tract infections
|
|
EP0433299B1
(en)
*
|
1988-08-02 |
1998-05-06 |
Gastro Services Pty. Limited (ACN 002 994 890) |
Treatment of gastro-intestinal disorders
|
|
US5443826A
(en)
*
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
DE4033996A1
(de)
*
|
1990-10-25 |
1992-04-30 |
Karl Heinz Hoelzel |
Enzymatisches stoffwechselprodukt zur symbioselenkung und verfahren zu seiner herstellung
|
|
GB2261372A
(en)
*
|
1991-11-15 |
1993-05-19 |
Gregor Reid |
Lactobacillus and skim milk compositions for prevention of urogenital infection
|
|
US5840318A
(en)
*
|
1993-05-11 |
1998-11-24 |
Immunom Technologies, Inc. |
Methods and compositions for modulating immune systems of animals
|
|
US8563522B2
(en)
*
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
|
US20020035071A1
(en)
*
|
1997-07-08 |
2002-03-21 |
Josef Pitha |
Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
|
|
US20060116330A1
(en)
*
|
1997-07-08 |
2006-06-01 |
The Iams Company |
Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
|
|
IT1299070B1
(it)
*
|
1998-04-10 |
2000-02-07 |
Proge Farm Srl |
Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US20050100559A1
(en)
*
|
2003-11-07 |
2005-05-12 |
The Procter & Gamble Company |
Stabilized compositions comprising a probiotic
|
|
US8894991B2
(en)
*
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
|
US20050158294A1
(en)
*
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
|
US20050152884A1
(en)
*
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
|
AR052472A1
(es)
*
|
2005-05-31 |
2007-03-21 |
Iams Company |
Lactobacilos probioticos para felinos
|
|
CA2607949C
(en)
*
|
2005-05-31 |
2012-09-25 |
Thomas William-Maxwell Boileau |
Feline probiotic bifidobacteria
|
|
AU2008211600B8
(en)
|
2007-02-01 |
2014-02-13 |
Mars, Incorporated |
Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
|
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
|
CA2807242C
(en)
|
2010-08-04 |
2017-05-02 |
Thomas Julius Borody |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
US9968638B2
(en)
|
2011-03-09 |
2018-05-15 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
US9675667B2
(en)
*
|
2015-02-10 |
2017-06-13 |
Massachusetts Institute Of Technology |
Isolated mucins and different microorganisms, and methods of use
|
|
MX2017014488A
(es)
|
2015-05-14 |
2018-06-11 |
Crestovo Holdings Llc |
Composiciones para transplante de la flora fecal y metodos para elaborarlos y utilizarlos y dispositivos para suministrarlos.
|
|
JP6856968B2
(ja)
|
2015-05-22 |
2021-04-14 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ |
自閉症スペクトラム障害および関連する症候を治療するための方法
|
|
CN105347511B
(zh)
*
|
2015-11-30 |
2018-02-27 |
威海地宝生物科技有限公司 |
一种水产养殖用复合微生物制剂及方法
|
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
US11026978B2
(en)
|
2016-10-11 |
2021-06-08 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
WO2018071536A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating primary sclerosing cholangitis and related disorders
|
|
US11040073B2
(en)
|
2017-04-05 |
2021-06-22 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
|
EP3606541A1
(en)
|
2017-04-05 |
2020-02-12 |
Crestovo Holdings LLC |
Compositions and methods for treating parkinson's disease (pd) and related disorders
|
|
WO2018218159A1
(en)
|
2017-05-26 |
2018-11-29 |
Crestovo Holdings Llc |
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
|
|
CA3072032A1
(en)
|
2017-08-07 |
2019-02-14 |
Finch Therapeutics, Inc. |
Compositions and methods for maintaining and restoring a healthy gut barrier
|
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
|
CA3114423A1
(en)
|
2018-09-27 |
2020-04-02 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|